This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.
DCIS
This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.
The PREDICT Registry:
-
Arizona Center for Cancer Care, Phoenix, Arizona, United States, 85027
Sutter Institute for Medical Research, Sacramento, California, United States, 95816
Mills-Peninsula Medical Center, San Mateo, California, United States, 94019
University of Colorado Denver, Aurora, Colorado, United States, 80045
UC Health - Memorial Hospital, Colorado Springs, Colorado Springs, Colorado, United States, 80909
St. Joseph's Hospital Tampa, Tampa, Florida, United States, 33614
Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02115
Dana-Farber/Brigham and Women's Cancer Center at South Shore, South Weymouth, Massachusetts, United States, 02190
Comprehensive Breast Care, Troy, Michigan, United States, 48098
Maimonides Cancer Center, Brooklyn, New York, United States, 11220
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
30 Years to 85 Years
FEMALE
No
PreludeDx,
Troy Bremer, PhD, PRINCIPAL_INVESTIGATOR, PreludeDx
Pat W Whitworth, MD, STUDY_CHAIR, PreludeDx
Rachel Rabinovitch, MD, STUDY_CHAIR, University of Colorado, Denver
Pat Borgen, MD, STUDY_CHAIR, Maimonides Medical Center
2035-12